Skip to content

High Intensity Interval Training After Stroke

The Effect of High Intensity Interval Training on Maximal Oxygen Uptake and Risk Factors for Recurrent Stroke

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02550015
Enrollment
70
Registered
2015-09-15
Start date
2015-09-30
Completion date
2018-12-02
Last updated
2020-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

Exercise training, Oxygen consumption

Brief summary

The purpose of this study is to examine if high intensity interval training after stroke is more effective than standard care to increase maximal oxygen uptake, reduce known risk factors for recurrent stroke and improve function.

Detailed description

Stroke is a leading cause of adult disability. Well designed studies have shown that the majority of the stroke population have low aerobic capacity and many are inactive. This is negative for their health and well-being. Physical inactivity may increase their risk of having recurrent stroke. The optimal training mode and intensity to improve aerobic capacity after stroke are not clear. High intensity interval training (ie. 90-95% of peak heart rate) has been proven to be more beneficial than moderate and low intensity exercise in order to improve maximal oxygen uptake in patients with cardiac disease. The response from this training on aerobic capacity and physical function in the stroke population are not known.

Interventions

BEHAVIORALHigh intensity interval training

Uphill treadmill walking

Standard care

Sponsors

Norwegian University of Science and Technology
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Approved informed consent * Independent walking \> 2 minutes * First episode of stroke (ischemic or hemorrhagic) * Minimum 3 months post-stroke * Living in the community and able to travel to assessment and training site * Approval to participate from the study's responsible medical doctor * Modified Rankin Scale 0-3

Exclusion criteria

* Impaired cognitive function to give valid informed consent to participate * Instability of cardiac conditions (ie. serious rhythm disorder, valve malfunction) * Other conditions where test of maximal oxygen uptake is contraindicated * Poorly controlled hypertension (\>180/100), measured at rest * \> 5 years post stroke * Subarachnoid hemorrhage * Participating in other ongoing intervention study * Other serious illness influencing testing of cardiorespiratory fitness and function at 1 year follow-up

Design outcomes

Primary

MeasureTime frameDescription
Maximal Oxygen Uptake1 year after inclusionA graded treadmill test of maximal oxygen uptake using a breath by breath ergospirometer

Secondary

MeasureTime frameDescription
Self reported physical activity level assessed by International Physical Activity Questionnaire8 weeks and 12 months after inclusion
Cognitive function assessed by Montreal Cognitive Assessment and Trail Making A and B8 weeks and 12 months after inclusion
Walking distance8 weeks and 12 months after inclusionWalking distance (in meters) will be measured with the 6 minute walk test.
Change in blood pressure (systolic and diastolic)8 weeks and 12 months after inclusionBlood pressure will be measured at rest
Walking speed8 weeks and 12 months after inclusionWalking speed (in minutes:seconds) will be measured with the 10 meter walk test and the Timed Up and Go test.
Leisure time activity and inactive time8 weeks and 12 months after inclusionUsing the ActivePal monitor attached to the participants non-affected leg information on position, walking and inactive time will be measured during 3 whole consecutive days.
Balance tested with the Bergs Balance Test8 weeks and 12 months after inclusion
Change in Blood tests8 weeks and 12 months after inclusionThe following blood tests will be taken: Hemoglobin, HDL, LDL, Cholesterol, Total Cholesterol, C peptides, Triglycerides and HbA1c
Independence assessed by Functional Independence Measure (FIM)8 weeks and 12 months after inclusion

Other

MeasureTime frameDescription
Anxiety and depression after stroke8 weeks and 12 months after inclusionHospital and Anxiety and Depression Scale will be used to get information about the participants level of anxiety and depression
Degree of disability and dependence8 weeks and 12 months after inclusionModified Rankin Scale (mRS)
Health status assessed by The Norwegian version of EQ-5D-5L questionnaire8 weeks and 12 months after inclusion
Submaximal oxygen consumption during treadmill walking8 weeks and 12 months after inclusionOxygen consumption will be measured at a standardized speed and inclination.
New cardiovascular or cerebrovascular incidents8 weeks and 12 months after inclusionGathered from the participants and their electronic journal system
Severity of stroke8 weeks and 12 months after inclusionThe Stroke Impact Scale will be used to evaluate how the stroke has affected the participants' health and life in addition to the National Institute of Health Stroke scale

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026